Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins

E-ISSN： 1873-4286|16|9|1143-1158

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.9, 2010-03, pp. : 1143-1158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Class of HIV-1 Inhibitors that Targets the Viral Envelope and Inhibits CD4 Receptor Binding

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1785-1793

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemistry and Biophysics of HIV-1 gp41 - Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2959-2984

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide and Non-peptide HIV Fusion Inhibitors

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 563-580

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1800-1809

Bentham Science Publishers

Access to resources Recommend Favorite

HIV entry and fusion inhibitors

By Chantry David

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite